Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Abbott Products has given $48m milestone payment to Depomed following the US Food and Drug Administration's approval of Gralise (gabapentin) tablets.
Subscribe to our email newsletter
Gralise tablet is developed by Depomed and is licensed to Abbott Products in US, Mexico and Canada.
The FDA has approved Gralise tablets as once daily treatment of post-herpetic neuralgia (PHN), which is pain following healing of the rash associated with shingles.
Depomed is a specialty pharmaceutical company with one approved product on the market and has developed another approved product, Glumetza.